Ethics Matters
Building the TRUST infrastructure for the psychedelic ecosystem
0B+
Global scale of suffering
1.2 billion people are living with a diagnosable mental-health disorder – that's 1 in 6 human beings.
WHO World Mental Health Report 2023
0%▲
COVID's after-shock
Clinical anxiety and major depression rose ≈ +26 % worldwide in 2020, an unprecedented jump in a single year.
The Lancet meta-analysis, 2021
0%
Care gap
Up to 75% of people in low- & middle-income countries receive no treatment for their condition.
WHO Mental-Health Atlas 2023
$0T
Economic drag
Depression & anxiety alone cost the global economy US $1 trillion each year in lost productivity.
WHO / World Bank, 2022
10 K
Average Cost
Australia ~30 K for MDMA or psilocybin therapy under current private-clinic pricing, 10-15K MDMA-assisted therapy for PTSD (nation-wide, once FDA reschedules), 3K-5K for Psilocybin in OR/CO
0 K
Facilitator Training Cost
Estimated cost for facilitator training programs.
Building a Safer, Ethical, & Accessible Future for the Well-Being of Humanity
Mind Lumen is focused on democratizing access to safe and ethical care. Ethics is the first trust filter for seekers choosing their providers — our goal is to make the therapeutic uses of these catalysts accessible to everyone, regardless of their financial means.
🌱 Our Philosophy
Healing and proactive cognitive wellbeing is a human right.
- Every person has the inherent right to explore their own consciousness — what we call cognitive liberty — without needing permission.
- Ethics can co-exist within capitalism, as long as there is a way to hold the industry accountable in an extractive system. We elevate the most ethical providers. learn more
- Cognitive liberty also means having the agency to know what you're consuming. We advocate for accessible, anonymous drug testing — because informed use is safer use.
Our Five Programs
Make It Possible
Your support builds the ethics infrastructure, equitable access, and independent research this industry needs.
DonateBuild With Us
Help us create experiential events, safe spaces, and the systems that make ethics measurable across the industry.
Join Our CommunityFollow the Work
Our Substack covers ethics, policy, research, and stories from the community.
Subscribe to NewsletterAdvisory Board
Integra – FounderAmanda Efthimiou | Advisor
Ensuring the highest codes of safety, transparency, and ethics are critical to everyone's transformative journeys with psychedelic medicines. I support psychedelic services and infrastructure that operates with deep integrity, and I'm confident in what MindLumen will offer to upgrade and elevate psychedelic standards of care.
EMBARK Approach – Co-DeveloperBill Brennan, PhD | Advisor
The promise of psychedelic healing is wholly contingent upon our ability to offer it in safe, ethical, and accessible ways. I am excited about the contributions that Mind Lumen will make on this front.
Decentralized Infra Architect • Ex-CTODerek Anderson | Technology Advisor
Mental health advancement is essential to our advancement as a species. Mindlumen has the potential to disrupt adoption of advance mental health practices and ensure a brighter, deeper and more introspective future.
Cofounder at Machina Scientia, Advisor to the Alexander Shulgin Research InstituteDr. James Keim | Advisor
Mental health advancement is essential to our advancement as a species. Mindlumen has the potential to disrupt adoption of advance mental health practices and ensure a brighter, deeper and more introspective future.
Neil Gehani | Founding Sherpa
The tremendous growth of psychedelics in both above and underground ecosystems with the lack of transparency, has also created ethical issues that lead to abuse, exploiting seekers even if it is unintentional, and causing more trauma instead of healing. Transparency and privacy are not mutually exclusive. The solution is to re-think how ethical businesses are built and held accountable so we shift from extractive to regenerative model of care.